Log in to save to my catalogue

Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile

Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8dc0c3b1d708411d896947c8d2845102

Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile

About this item

Full title

Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile

Publisher

Basel: MDPI AG

Journal title

Gastrointestinal Disorders, 2023-08, Vol.5 (3), p.317-328

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Metoclopramide has been the cornerstone of gastroparesis management for the past 40 years as it is the only FDA-approved medication for gastroparesis. Other medications such as erythromycin and domperidone have been used off-label with variable efficacy. Historically, metoclopramide has been used in oral, intravenous, and subcutaneous formulations....

Alternative Titles

Full title

Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8dc0c3b1d708411d896947c8d2845102

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8dc0c3b1d708411d896947c8d2845102

Other Identifiers

ISSN

2624-5647

E-ISSN

2624-5647

DOI

10.3390/gidisord5030026

How to access this item